BioSig Technologies Inc.

BioSig Technologies Inc. is a medical technology company that specializes in developing advanced biomedical signal processing solutions. Its primary function is to enhance the performance and accuracy of cardiac electrophysiology data analysis, ultimately improving the diagnostic capabilities of healthcare providers. The company's notable creation, the PURE EP System, is designed to provide significant advancements in electrophysiology procedures by delivering clearer and more precise signals to clinicians treating arrhythmias. BioSig Technologies operates within the healthcare technology sector, impacting hospitals, research institutions, and clinics that prioritize innovative solutions for cardiac care. Based in the United States and founded in 2009, BioSig Technologies plays a significant role in the medical field by striving to transform how cardiac arrhythmias are understood and treated, thus contributing to the evolution of patient care and procedural efficiency.

Sector

Healthcare

Industry

Medical Devices

CEO

Mr. Karl Henry McPhie

Employees

5

Headquarters

Los Angeles, CA, United States

Website

www.biosig.com